drugset / Trial / NCT00025467
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have recurrent or persistent endometrial cancer. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor
Timeline
- Start
- 2001-09
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |